The Complexity Signature: Developing a Tool to Communicate Biopsychosocial Severity of Disease for Children with

Sandro M Krieg1, Sebastian Sonanini2, Nico Sollmann1

  • 1Department of Neurosurgery, Klinikum rechts der Isar, TU München, Munich, Germany.

Neuropediatrics
|May 27, 2016
PubMed

Insights

A new severity score aids in assessing children with chronic neurological diseases by considering biopsychosocial factors. This tool is recommended by pediatricians for clinical use, improving interdisciplinary communication.

Area of Science:

  • Pediatric Neurology
  • Biopsychosocial Medicine
  • Clinical Assessment Tools

Background:

  • Children with medical complexity require interdisciplinary approaches based on the biopsychosocial model.
  • Existing assessment methods may not fully capture the multifaceted needs of pediatric patients with chronic neurological conditions.

Purpose of the Study:

  • To develop and validate a standardized, visualized severity score for chronic neurological diseases in children.
  • To evaluate the score's applicability and usefulness in clinical practice among pediatricians.

Main Methods:

  • Identification of key dimensions within the biopsychosocial model relevant to pediatric neurological conditions.
  • Development of a five-grade severity score across selected neuropediatric subsections.
  • Validation through illustrative patient cases and comparison with direct assessment using Spearman correlation coefficient.

Main Results:

  • Nine dimensions formed the basis of the developed severity score.
  • The score demonstrated applicability and usefulness, with all board-certified pediatricians recommending its clinical use.
  • A good correlation was found between direct patient assessment and the indirect severity score.

Conclusions:

  • The developed severity score effectively integrates biopsychosocial aspects of chronic pediatric diseases.
  • The score is comprehensible, easily applicable in clinical routine, and serves as a communication tool for interdisciplinary teams.
  • Further refinement with larger patient cohorts is suggested for future studies.

Related Concept Videos

Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.0K
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.6K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
969
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
315
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K